-
Teva launches generic Xeloda tablets
JERUSALEM — Teva Pharmaceutical Industries will launch the generic version of Xeloda (capecitabine) tablets, 150 mg and 500 mg, in the United States. The drug is used to treat cancers that have metastasized.
Xeloda tablets, 150 mg and 500 mg had annual sales in the United States of approximately $754 million as of December 2013, according to IMS. -
Nabisco expands Brown Rice Triscuit line
EAST HANOVER, N.J. — Nabisco's Brown Rice Triscuit line is expanding to include Brown Rice Triscuit Thin Crisps, which the company said is a new approach to the classic wheat flavor and texture.
The new snack is available in three flavors: Sour Cream & Chive, Wasabi & Soy Sauce and Cinnamon Sugar. Brown Rice Triscuit Thin Crisps are baked with 100% whole-grain brown rice and whea, and pack 23 g of whole grains per 30 g serving.
Consumers can find them at retailers nationwide for a suggested retail price of $3.69 for a 7.6-oz. box.